FDA Drug Recalls

Recalls / Class II

Class IID-1013-2016

Product

TESTOSTERONE CYPIONATE 150MG/ML, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

Affected lot / code info
Lot #: 01042016:26@3, Exp.04/03/2016; Lot #: 01072016: 10@15, Exp.04/06/2016; Lot #: 02032016:41@16, Exp. 05/03/2016; Lot #: 03152016: 62@44, Exp.06/15/2016; Lot #: 04292016:35@11, Exp. 07/31/2016.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Recalling firm

Firm
Well Care Compounding Pharmacy
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
3430 E Tropicana Ave Ste 9, N/A, Las Vegas, Nevada 89121-7345

Distribution

Quantity
869 Units (Total All Products)
Distribution pattern
NV

Timeline

Recall initiated
2016-05-17
FDA classified
2016-06-09
Posted by FDA
2016-06-15
Terminated
2017-01-13
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1013-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls